NYSE - Delayed Quote • USD
Impact BioMedical Inc (IBO)
At close: November 17 at 9:37 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
50.00
Operating Expense
4,028.00
4,028.00
3,454.00
3,454.00
Operating Income
-4,028.00
-4,028.00
-3,454.00
-3,404.00
Net Non Operating Interest Income Expense
-431.00
-431.00
-438.00
-438.00
Other Income Expense
52.00
52.00
-3,984.00
-4,034.00
Pretax Income
-4,407.00
-4,407.00
-7,876.00
-7,876.00
Tax Provision
--
--
-621.00
-621.00
Net Income Common Stockholders
-4,336.00
-4,336.00
-7,051.00
-7,051.00
Diluted NI Available to Com Stockholders
-4,336.00
-4,336.00
-7,051.00
-7,051.00
Basic EPS
-0.36
--
-0.59
-0.59
Diluted EPS
-0.36
--
-0.59
-0.59
Basic Average Shares
12,000.00
--
12,000.00
12,000.00
Diluted Average Shares
12,000.00
--
12,000.00
12,000.00
Total Operating Income as Reported
-4,028.00
-4,028.00
-3,454.00
-3,404.00
Total Expenses
4,028.00
4,028.00
3,454.00
3,454.00
Net Income from Continuing & Discontinued Operation
-4,336.00
-4,336.00
-7,051.00
-7,051.00
Normalized Income
-4,336.00
-4,336.00
-3,274.90
-3,274.90
Interest Income
13.00
13.00
24.00
24.00
Interest Expense
444.00
444.00
462.00
462.00
Net Interest Income
-431.00
-431.00
-438.00
-438.00
EBIT
-3,963.00
-3,963.00
-7,414.00
-7,414.00
EBITDA
-2,843.00
-2,843.00
-6,301.00
-6,301.00
Reconciled Depreciation
1,120.00
1,120.00
1,113.00
1,113.00
Net Income from Continuing Operation Net Minority Interest
-4,336.00
-4,336.00
-7,051.00
-7,051.00
Total Unusual Items Excluding Goodwill
--
--
-4,100.00
-4,100.00
Total Unusual Items
--
--
-4,100.00
-4,100.00
Normalized EBITDA
-2,843.00
-2,843.00
-2,201.00
-2,201.00
Tax Rate for Calcs
--
--
0.00
0.00
Tax Effect of Unusual Items
--
--
-323.90
-323.90
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade